NOVEL THERAPY FOR BRAIN METASTASIS KU Leuven
Despite research advances, cancer still remains a major life threat with increasing societal burdens. Previously, the theragnostic laboratory at KU Leuven has developed an ingenious small molecule dual targeting pan-anticancer theragnostic strategy called OncoCiDia, which combines tumor necrotizing effect by using a vascular disrupting agent such as Combretastatin A-4 phosphate (CA4P) and targeted radiotherapy by using a necrosis-avid ...